HIV pre‐exposure prophylaxis (PrEP), the use of HIV treatment medication by people at risk of HIV to reduce their risk of acquisition, has emerged over recent years as a highly‐effe­ctive HIV …

PrEP nurses run clinics on Monday and Tuesday and Friday each week. A sexual health specialist has a Wednesday clinic each week. This clinic is only available to people with …

Evaluation of preexposure (PrEP) eligibility criteria, using sexually transmissible infections as markers of human immunodeficiency virus (HIV) risk at enrollment in PrEPX, a large …

WHO defines pre-exposure prophylaxis (PrEP) as the use of oral tenofovir disoproxil fumarate (TDF) or co-formulated TDF/emtricitabine (TDF/FTC) or co-formulated TDF/lamivudine …

We describe a study protocol that aims to demonstrate if the provision of PrEP to up to 3800 individuals at risk of HIV in Victoria, Australia reduces HIV incidence locally by 25% generally …

Evaluation of preexposure (PrEP) eligibility criteria, using sexually transmissible infections as markers of human immunodeficiency virus (HIV) risk at enrollment in PrEPX, a large …

Jul 1, 2019 · We surveyed 970 PrEPX study participants to evaluate interest in switching from daily to on-demand PrEP in a study setting.

Methods: PrEPX is a population level intervention study in Victoria, Australia in which generic PrEP will be delivered to 3800 individuals for up to 36 months. Study eligibility is consistent …

PrEP involves the use of HIV medications (co-formulated tenofovir disoproxil with emtricitabine [TD/FTC]) by people who are HIV negative to reduce their risk of HIV from potential exposure …

eXpanded (PrEPX) is a new study that will expand the provision of PrEP to 3,200 Victorians who have a high chance of acquiring HIV. Alfred Health is responsible for conducting the study.